Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

NAFOXIDINE HYDROCHLORIDE

NFPA

PRODUCT USE

Intermediate. Inhibits oestradiol binding to the 8S binding protein. Used in a bioassay
for oestrogenic activity.

SYNONYMS

C29-H31-N-O2, C29-H31-N-O2, "1-[2-(p-(2, 3-dihydro-6-methoxy-2-phenyl-1-
naphthyl)phenoxyethyl]pyrrolidine hydrochloride", "1-[2-(p-(2, 3-dihydro-6-methoxy-2-
phenyl-1-naphthyl)phenoxyethyl]pyrrolidine hydrochloride", "1-[2-(p-(6-methoxy-2-phenyl-3,
4-dihydro-1-naphthyl)phenoxy)ethyl]-pyrrolidine hydrochloride", "1-[2-(p-(6-methoxy-2-
phenyl-3, 4-dihydro-1-naphthyl)phenoxy)ethyl]-pyrrolidine hydrochloride", 11100A, U-11100A

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

EMERGENCY OVERVIEW

RISK

Harmful if swallowed.

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  Accidental ingestion of the material may be harmful; animal experiments indicate that ingestion of less than 150 gram may be fatal or may produce serious damage to the health of the individual.  Considered an unlikely route of entry in commercial/industrial environments.  

EYE

  Although the material is not thought to be an irritant, direct contact with the eye may produce transient discomfort characterized by tearing or conjunctival redness (as with windburn).  

SKIN

  The material is not thought to produce adverse health effects or skin irritation following contact (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable gloves be used in an occupational setting.  This material is a photosensitizer. Certain individuals working with this substance may show allergic reaction of the skin under sunlight. This results in sensitivity to sunburn (may be severe) unless protective covering and 15+PF sunscreen are used. Responses may vary from sunburn-like effects to swelling and blistering lesions.  

INHALED

  The material is not thought to produce adverse health effects or irritation of the respiratory tract (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable control measures be used in an occupational setting.  Persons with impaired respiratory function, airway diseases and conditions such as emphysema or chronic bronchitis, may incur further disability if excessive concentrations of particulate are inhaled.  

CHRONIC HEALTH EFFECTS

  Principal routes of exposure are by accidental skin and eye contact andinhalation of generated dusts.  No human exposure data available. For this reason health effects described are based on experience with chemically related materials.  As with any chemical product, contact with unprotected bare skin; inhalation of vapor, mist or dust in work place atmosphere; or ingestion in any form, should be avoided by observing good occupational work practice.